PERSPECTA

News from every angle

← Back to headlines

Allogene Therapeutics Names Zachary Roberts as New CEO

Allogene Therapeutics has appointed Zachary Roberts as its new Chief Executive Officer, part of a planned succession.

28 May, 21:29 — 28 May, 21:29
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed12d ago

Allogene Therapeutics names Zachary Roberts CEO in planned succession

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Mercedes-Benz Enters Drone Sector

14m ago

INLIF Secures $4.4M Battery Cell Packaging Machine Contract

15m ago

Expert Advice on Reducing Cyber Risk for Small Businesses

15m ago